Elanco Animal Health (ELAN) Tops Q1 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Elanco Animal Health Reports First Quarter Results
May 9, 2019 6:29 AM EDTGross margin (reported) improved 190 basis points to 53.0 percent of revenue Earnings per share (EPS) was $0.09 (reported), or $0.25 (adjusted) Revenue declined 1 percent to $731.1 million; Total and Core Revenue both grew 2 percent at constant currency rates Revenue from Innovation portfolio grew 59 percent, represents 13 percent of total revenue Announced agreement to acquire Aratana Therapeutics and collaboration with VetDC Expected 2019 revenue updated to be between $3.08 billion and $3.14 billion due to changes in foreign exchange rate... More
